β-Hydroxybutyrate Protects Against Cisplatin-Induced Renal Damage via Regulating Ferroptosis
Cisplatin is a particularly potent antineoplastic drug. However, its usefulness is restricted due to the induction of nephrotoxicity. More recent research has indicated that β-hydroxybutyrate (β-HB) protects against acute or chronic organ damage as an efficient healing agent. Nonetheless, the therap...
Saved in:
| Main Authors: | Ruixue Tian, Shuqin Tang, Jingyu Zhao, Yajie Hao, Limei Zhao, Xiutao Han, Xingru Wang, Lijun Zhang, Rongshan Li, Xiaoshuang Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2354918 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production
by: Yan Tian, et al.
Published: (2025-12-01) -
4-Methoxylonchocarpin protects against cisplatin induced acute kidney injury via regulating ferroptosis
by: Nan Jiao, et al.
Published: (2025-12-01) -
CAMKKβ supports growth and viability of epithelial ovarian cancer in vitro and in vivo
by: Matthew J. Borrelli, et al.
Published: (2025-07-01) -
Cisplatin‐induced nephrotoxicity and the protective effect of fosfomycin on it as demonstrated by using a crossover study of urinary metabolite levels
by: Masatoshi Hayashi, et al.
Published: (1997-06-01) -
RXRα modulates hepatic stellate cell activation and liver fibrosis by targeting CaMKKβ–AMPKα axis
by: Lijun Cai, et al.
Published: (2025-07-01)